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CASE  REPORT
Introduction
Neurofibromatosis type 1 (NF-1) is one of the most
common neurogenetic disorders, affecting approxi-
mately 1 in 3,000 individuals worldwide. Complications
arising from gastrointestinal lesions have been reported
in 25% of patients with NF-1. The incidence of gastro-
intestinal stromal tumor (GIST) among NF-1 patients
is approximately 3.9–25%,1 and this relationship is
generally considered to be non-coincidental.2
We report a male patient with NF-1 who underwent
repeated laparotomies due to recurrent retroperitoneal
and intra-abdominal tumor rupture. According to the
histologic features and immunohistochemical (IHC)
stain results, the tumors represent recurrent GISTs.
Case Report
In June 1991, a 50-year-old man with NF-1 associated
with multiple cutaneous neurofibromas and café-au-
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lait spots presented with epigastric pain and oliguria
for 20 days. He experienced an episode of near-
fainting and was sent to our emergency department.
On arrival, he was pale and ill-looking, with a blood
pressure of 80/50 mmHg. Physical examination
revealed abdominal distension and diffuse tenderness
with signs of peritoneal irritation. Abdominal computed
tomography (CT) scan showed plenty of intra-
abdominal fluids compatible with internal bleeding. A
space-occupying mass with an enhanced capsule was
found over the lower pelvis just above the urinary
bladder, suggesting a tumor with bleeding (Figure 1).
The patient underwent emergency laparotomy. An
estimated 2,000 mL of bloody ascites was drained and
a huge tumor, adhering to the jejunum, colon and
omentum, was resected. The postoperative period was
uneventful. Pathology revealed an encapsulated tumor
mass measuring 16 × 14 × 10 cm in size, with a
ruptured hemorrhagic area measuring 4 × 4 cm and
areas of peritoneal attachment. Microscopically, the
tumor was composed of long fascicles of spindle cells
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with focal nuclear palisading. Mild nuclear pleomor-
phism, common mitotic figures and frequent hemor-
rhage were seen. The features were consistent with
well-differentiated malignant schwannoma.
The patient remained asymptomatic until 7 years
later, when he suffered from abdominal fullness for 1
month and abdominal pain for 5 days. Abdominal CT
revealed a retroperitoneal space-occupying lesion and
mild bloody ascites. In the second laparotomy, a 12 ×
9 × 5 cm mass was found at the fourth portion of the
duodenum, just below the Treitz ligament. Due to the
tumor’s adhesion to the duodenal wall, en bloc resection
of the tumor and part of the duodenal wall was
performed. The postoperative period was smooth. On
microscopic examination, the tumor was cellular,
composed of pleomorphic and spindle cells with wavy
nuclei. It had invaded the duodenal wall but spared the
mucosa. IHC stain showed tumor cells positive for
S-100 but negative for smooth muscle actin (SMA).
The pathologic diagnosis was malignant peripheral
nerve sheath tumor (MPNST).
Six years later, the patient experienced right lower
quadrant pain for a few days. Abdominal CT revealed a
pelvic tumor and mild hemoperitoneum (Figure 2).
Recurrent malignancy with tumor rupture was highly
suspected, and during the third laparotomy, 3 tumors
were found. A hemorrhagic ruptured tumor measuring
4 × 5 × 3 cm was found invading the posterior wall of
the urinary bladder, a 7 × 6 × 5 cm tumor was found in
the mesenteric side of the jejunum, and a 1.5 × 1 × 1 cm
tumor was found attached to the ileum. On microscopic
section, the 3 tumors were composed of spindle cells
with moderate to high cellularity. Nuclear atypia was
mild to moderate. Mitoses were occasionally seen in the
jejunal tumor (about 2–5/50 high-powered field, HPF),
and more frequently seen in the pelvic mass (5/50
HPF). All 3 tumors were positive for CD117, focally
positive for CD34, SMA and S-100, and negative for
desmin. The pathologic diagnosis was malignant GIST
with focal smooth muscle and neurogenic differentiation.
To confirm the impression of recurrent GIST, the
specimen from the first laparotomy was reviewed and
IHC staining performed. The tumor was strongly
positive for CD117 (Figure 3), CD34, SMA and
S-100, but negative for desmin. It fulfilled the criteria
for GIST.
Discussion
NF-1, also known as von Recklinghausen’s disease, is
characterized by multiple peripheral neurofibromas,
Figure 1. Before the first laparotomy, computed tomography scan
showed a tumor measuring 15 cm in diameter in the pelvis;
intratumoral hemorrhage and massive bloody ascites were found.
Figure 2. (A) Abdominal computed tomography scan during the third episode showed a space-occupying lesion, 7 cm in diameter, in
the pelvis. There was only minimal ascites due to the previous operations and severe lower abdomen adhesion. (B) Moderate ascites
was found in the upper abdomen (cephalad section to Figure 2A).
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café-au-lait macules, skinfold freckling, and iris
hamartoma (Lisch nodules).3 The gastrointestinal
lesions arise during midlife, later than cutaneous
lesions. The predominant lesions are benign
neurofibromas or leiomyomas involving the jejunum
and stomach, with rare involvement of the colon.
The incidence of these tumors, which tend to be
multiple in the gastrointestinal tract, is uncertain
because the diagnosis is made only in symptomatic
patients. A significant number of patients with NF-1
never manifest gastrointestinal bleeding, obstruction
or abdominal pain, which are the 3 most common
symptoms of these tumors.4
In the 1960s, Stout5 and Kay and Still6 used
the terms “leiomyoma”, “leiomyosarcoma”,
“leiomyoblastoma” and “bizarre leiomyoma” to
describe gastrointestinal stroma cell tumors. With the
introduction of IHC staining in the 1980s and the
discovery of CD117 in the 1990s, GIST has become
a generic name for primary nonepithelial tumors of the
gastrointestinal tract.2
Surgery is the mainstay of treatment for GIST.
Radiation and chemotherapy with currently available
agents are of uncertain value.7 Recent dramatic
improvements have been achieved using STI571
(Glivec®, Novartis AG, Basel, Switzerland) in cases of
metastatic, recurrent or unresectable GIST. Glivec®
inhibits mutant KIT tyrosine kinase, which appears to
play a critical role in the pathogenesis of GIST.3
Generally, the combination of size less than 2 cm
and low mitotic rate (< 5/50 HPF) translates to a
benign clinical course. Tumors larger than 5 cm in
diameter or with mitotic activity exceeding 5 mitoses
per 50 HPFs show high potential for intra-abdominal
and liver metastasis.8 It has been reported that the
5-year survival rate after complete GIST resection is
63%, compared to 10% after incomplete resection.9
Furthermore, the 5-year survival rate for completely
excised low-grade GIST is 72%, compared to 18% for
high-grade GIST.10 Tumor rupture, whether spon-
taneous or iatrogenic, is associated with a decreased
overall survival rate and an increased rate of early
recurrence,11 because intraperitoneal seeding and
metastasis may occur after tumor rupture.
Although the tumors are often soft, fragile, and
prone to rupture during resection, only a few cases
presenting with hemoperitoneum have been reported.
Cystic change is often found in GIST, even when the
tumor is small.12 Cheon et al13 claimed that cystic
degeneration within the mass may cause weakness of
the tumor capsule. Karatzas et al14 postulated that
hemoperitoneum might be related to the rupture of
the capsular vessel on the tumor surface. Examination
of our specimens showed no cystic degeneration;
erosion of the friable neovascularity associated with
extensive intratumoral hemorrhage and rapid expansion
of the tumor mass may have caused the spontaneous
tumor rupture.
Due to the nature of the local recurrence of
malignant GIST, and the similar histologic features
of our tumors, we considered them to be of similar
type. IHC staining can help us to differentiate
schwannoma, MPNST and GIST. Almost all GISTs
are CD117-positive, 70% are CD34-positive, a
minority are positive for S-100, occasionally positive
for SMA and desmin, and negative for glial fibrillary
acidic protein (GFAP). Schwannomas are almost
always positive for S-100 and GFAP, occasionally
positive for CD34, and negative for CD117, SMA
and desmin. MPNSTs are positive for neuron-specific
enolase and GFAP, and they also exhibit a mixed
proliferation of cells positive for S-100 protein,
epithelial membrane antigen and CD34, indicating a
heterogeneous composition of the constituents.
Gastrointestinal manifestations of NF-1 have been
well described. Some authors estimate that 3.9–25% of
patients with NF-1 have gastrointestinal tumors, but
less than 5% actually have associated symptoms.15,16
Although this is generally considered to be non-
coincidental, the definite relationship between NF-1
and GIST based on molecular biology remains to be
determined.17 We, therefore, recommend that non-
epithelial tumors of the gastrointestinal tract in pa-
tients with neurofibromatosis be reviewed to exclude
the possibility of GIST, a tumor that is highly respon-
sive to target therapy. We also suggest that NF-1 pa-
tients with gastrointestinal complaints receive further
survey to rule out GIST.
Figure 3. Immunohistochemical stain was performed on the
specimen from the first laparotomy. The cells were strongly
positive for CD117 (CD117, original magnification × 100).
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